Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Broken leg in cast © SHUTTERSTOCK

Immediately after a major injury pain is expected. However, after an injury has healed, six out of every ten people continue to experience pain for years afterwards. Research has shown that people with long-term pain after a leg injury are more likely to develop long-term disability and have poorer quality of life than people who do not have pain.

It has also been found that beliefs and behaviours during recovery from injury can impact the outcome. For example, a person who believes they can perform activities whilst in pain will use less medication and be less disabled than those who believe they should not undertake activities if they experience pain.

David Keene, University Research Lecturer at NDORMS and lead researcher said: "Cognitive Behavioural Therapy (CBT) has proved useful in long-term pain management, enabling patients to achieve a better quality of life. In this study we will use it much earlier after major injury to see if we can reduce the impact of pain and help improve recovery."

The treatment focuses on improving patient's confidence to manage pain and return to meaningful activities even if pain persists. It involves strategies such as planning daily activities, setting goals and relaxation exercises. Trained rehabilitation team members will introduce patients to the treatment prior to hospital discharge and sessions will continue afterwards.

The study will test the treatment by recruiting sixty patients after a major leg injury from five hospitals to a feasibility study to assess how it works in practice.

The team includes health researchers and clinical experts in psychology, pain, rehabilitation and surgery. It is being designed in collaboration with Patient and Public Involvement (PPI) representatives who will help to produce the treatment materials and be involved throughout the study.

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.